198 related articles for article (PubMed ID: 3006831)
1. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.
Miller W; Flynn P; McCullough J; Balfour HH; Goldman A; Haake R; McGlave P; Ramsay N; Kersey J
Blood; 1986 Apr; 67(4):1162-7. PubMed ID: 3006831
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infections after allogeneic bone marrow transplantation.
Winston DJ; Ho WG; Champlin RE
Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
[TBL] [Abstract][Full Text] [Related]
5. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation.
Wingard JR; Chen DY; Burns WH; Fuller DJ; Braine HG; Yeager AM; Kaiser H; Burke PJ; Graham ML; Santos GW
Blood; 1988 May; 71(5):1432-7. PubMed ID: 2833959
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
Funada H; Harada M; Yoshida T; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection.
Atkinson K; Downs K; Golenia M; Biggs J; Marshall G; Dodds A; Concannon A
Br J Haematol; 1991 Sep; 79(1):57-62. PubMed ID: 1654994
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
Miller WJ; McCullough J; Balfour HH; Haake RJ; Ramsay NK; Goldman A; Bowman R; Kersey J
Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants.
Humar A; Wood S; Lipton J; Messner H; Meharchand J; McGeer A; MacDonald K; Mazzulli T
Clin Infect Dis; 1998 Mar; 26(3):606-10. PubMed ID: 9524831
[TBL] [Abstract][Full Text] [Related]
12. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response.
Stals FS; Steinhoff G; Wagenaar SS; van Breda Vriesman JP; Haverich A; Dormans P; Moeller F; Bruggeman CA
Lab Invest; 1996 Feb; 74(2):343-52. PubMed ID: 8780154
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
15. CMV antigenemia following bone marrow transplantation: risk factors and outcomes.
Osarogiagbon RU; Defor TE; Weisdorf MA; Erice A; Weisdorf DJ
Biol Blood Marrow Transplant; 2000; 6(3):280-8. PubMed ID: 10871153
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cytomegalovirus infection after human marrow transplantation.
Meyers JD; Flournoy N; Thomas ED
J Infect Dis; 1986 Mar; 153(3):478-88. PubMed ID: 3005424
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML.
Jacobsen N; Lönnqvist B; Ringdén O; Rajantie J; Siimes MA; Volin L; Ruutu T; Nikoskelainen J; Toivanen A; Ryder L
Eur J Haematol; 1987 Apr; 38(4):350-5. PubMed ID: 3038601
[TBL] [Abstract][Full Text] [Related]
18. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection after marrow transplantation for aplastic anemia.
Ljungman P; Niederwieser D; Pepe MS; Longton G; Storb R; Meyers JD
Bone Marrow Transplant; 1990 Nov; 6(5):295-300. PubMed ID: 1963336
[TBL] [Abstract][Full Text] [Related]
20. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Van Lint MT; Uderzo C; Locasciulli A; Majolino I; Scimé R; Locatelli F; Giorgiani G; Arcese W; Iori AP; Falda M; Bosi A; Miniero R; Alessandrino P; Dini G; Rotoli B; Bacigalupo A
Blood; 1998 Oct; 92(7):2288-93. PubMed ID: 9746766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
